Translating Research into Highest Quality Patient Care

DSRB Announcements

DSRB Announcements for 2024

26 Mar 2024

DSRB-260324: Revised DSRB Review Fees for FY2024

DSRB Announcements for 2023

29 Dec 2023

DSRB-291222: Revised DSRB Review Fees, to reflect prevailing 9% GST rate in 2024

DSRB-291223: Adjustments to FCOI Declaration Cycle 2023-2025

27 Oct 2023

DSRB-271023: Re-Classification of Studies involving Anonymised Data and/or Human Biological Material as Review Not Required 

08 Mar 2023

DSRB-080323: Renewal Fee for Industry Sponsored Studies 


DSRB Announcements for 2022

30 Dec 2022

DSRB-301222: Revised DSRB Review Fees, to reflect prevailing 8% GST rate in 2023

05 Sep 2022

DSRB-050922: Enhancements to Studies under Data Analysis Stage 

DSRB-050922: ROAM Enhancement for Minimum Training Status 

07 Mar 2022

DSRB-070322: Revised DSRB Review Fees 

14 Feb 2022

DSRB-140222: Updated ICF and Assent Form Template Announcement 


To see older DSRB Announcements (2021 and earlier), please click here.


For any further queries, please contact the DSRB via the contact list below.

Domain Specific Review Board (DSRB)
c/o National Healthcare Group, Research & Development Office (RDO)
Nexus @One-North (South Tower), No. 3 Fusionopolis Link, #03-08, Singapore 138543
DSRB Hotline: (65) 6471 3266; Fax : (65) 6496 6257
(Download DSRB Secretariat Contact List here )